GlassScriptPhysician profile
Ernest Olin Pugh
NPI 1831163575
$1,260.52
in general payments reported to CMS, 2019-2025
19 companies · $58.67 in 2025
The $58.67 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $946 · 2020: $157 · 2023: $54.33 · 2024: $43.96 · 2025: $58.67.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $157.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $156.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $274.90 | 2019-2020 | |
| Novo Nordisk INC | $176.95 | 2019-2023 | Wegovy |
| Janssen Pharmaceuticals, INC | $148.76 | 2019-2020 | |
| Amarin Pharma, INC. | $102.63 | 2019-2020 | |
| Amgen INC. | $81.07 | 2019 | |
| Merck Sharp & Dohme LLC | $73.87 | 2019 | |
| Pfizer INC. | $70.06 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $50.96 | 2019-2020 | |
| Lilly USA, LLC | $41.00 | 2019-2023 | Mounjaro |
| Glaxosmithkline, LLC. | $38.70 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $33.08 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $27.96 | 2019 | |
| Ani Pharmaceuticals, INC. | $25.96 | 2025 | Purified Cortrophin Gel |
| Abbott Laboratories | $23.61 | 2024 | Id Now Instrument |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $20.35 | 2024 | Caplyta |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $20.26 | 2019 | |
| Genentech USA, INC. | $17.97 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.48 | 2025 | |
| Sanofi Pasteur INC. | $15.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ernest Pugh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.